Insider Transactions

What Fusion Pharmaceuticals Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	0	0
Total trades	0	0

Shares traded

	3 months	12 months
Acquired	0	0
Disposed	0	0
Net activity	+0	+0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Crowley John J	Chief Financial Officer	Jun 04	Disposition to Issuer · D	−10,410	—	—	0
Gannon Steven	Director	Jun 04	Disposition to Issuer · D	−56,400	—	—	0
Leamon Christopher P	Chief Scientific Officer	Jun 04	Disposition to Issuer · D	−11,957	—	—	0
Burak Eric	Chief Technology Officer	Jun 04	Disposition to Issuer · D	−38,490	—	—	0
Rawat Mohit	President & CBO	Jun 04	Disposition to Issuer · D	−21,699	—	—	0
Valliant John	Chief Executive Officer	Jun 04	Disposition to Issuer · D	−318,147	—	—	0
Leamon Christopher P	Chief Scientific Officer	Aug 31	Grant / award · A	+11,957	—	—	11,957
Rawat Mohit	President & CBO	Aug 31	Grant / award · A	+12,843	—	—	12,843
Khuong Chau Quang	Director	Nov 11	Grant / award · A	+42,093	$2.38	+$100K	42,093
Gannon Steven	Director	Aug 11	Open-market buy · P	+44,400	$2.03	+$90.1K	56,400
Valliant John	Chief Executive Officer	Apr 27	Disclosed 10b5-1 sale · S	−4,511	$6.03	−$27.2K	318,147
Valliant John	Chief Executive Officer	Apr 26	Disclosed 10b5-1 sale · S	−2,147	$6.07	−$13K	322,658
Valliant John	Chief Executive Officer	Apr 25	Disclosed 10b5-1 sale · S	−2,036	$6.03	−$12.3K	324,805
Valliant John	Chief Executive Officer	Apr 21	Disclosed 10b5-1 sale · S	−922	$6.01	−$5.54K	326,841
Valliant John	Chief Executive Officer	Apr 20	Disclosed 10b5-1 sale · S	−367	$6.02	−$2.21K	327,763
Valliant John	Chief Executive Officer	Apr 13	Disclosed 10b5-1 sale · S	−11,994	$6.41	−$76.9K	328,130
Valliant John	Chief Executive Officer	Apr 12	Disclosed 10b5-1 sale · S	−18,255	$7.10	−$130K	340,124
Valliant John	Chief Executive Officer	Apr 11	Disclosed 10b5-1 sale · S	−2,600	$7.37	−$19.2K	358,379
Valliant John	Chief Executive Officer	Apr 08	Disclosed 10b5-1 sale · S	−826	$7.52	−$6.21K	360,979
Valliant John	Chief Executive Officer	Apr 07	Disclosed 10b5-1 sale · S	−1,255	$7.56	−$9.49K	361,805

Page 1 of 6 · showing the 20 most recent Sign up free to view all 102 transactions and filter by insider →

Comments